101 related articles for article (PubMed ID: 28025846)
1. Prolactin and growth hormone immunoactivity in canine mammary adenomas and adenocarcinomas.
Bohrer ER; Löhr CV; Kutzler MA
Reprod Domest Anim; 2017 Apr; 52 Suppl 2():293-297. PubMed ID: 28025846
[TBL] [Abstract][Full Text] [Related]
2. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
[TBL] [Abstract][Full Text] [Related]
3. Prolactin binding in benign and malignant mammary tissue of female dogs.
Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
[TBL] [Abstract][Full Text] [Related]
4. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical technique for detection of prolactin (PRL) and growth hormone (GH) in hyperplastic and neoplastic lesions of dog prostate and mammary gland.
El Etreby MF; Mahrous AT
Histochemistry; 1979; 64(3):279-86. PubMed ID: 93102
[TBL] [Abstract][Full Text] [Related]
6. Immunohistological assessment of fibrin deposition and thrombus formation in canine mammary neoplasia.
Golombiewski A; Gutberlet K; Rudolph R
J Comp Pathol; 1997 Aug; 117(2):177-83. PubMed ID: 9352443
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural study of mixed growth hormone & prolactin secreting pituitary adenomas.
Sarkar C; Dinda AK; Roy S; Kochupillai N; Kharbanda K; Tandon PN
Indian J Med Res; 1992 Aug; 96():209-14. PubMed ID: 1428057
[TBL] [Abstract][Full Text] [Related]
8. Prolactin--to be reconsidered in canine mammary tumourigenesis?
Michel E; Rohrer Bley C; Kowalewski MP; Feldmann SK; Reichler IM
Vet Comp Oncol; 2014 Jun; 12(2):93-105. PubMed ID: 22738741
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
Griffey SM; Madewell BR; Dairkee SH; Hunt JE; Naydan DK; Higgins RJ
Vet Pathol; 1993 Mar; 30(2):155-61. PubMed ID: 7682368
[TBL] [Abstract][Full Text] [Related]
10. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors in canine mammary gland tumours.
Sobczak-Filipiak M; Malicka E
Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
[TBL] [Abstract][Full Text] [Related]
12. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma.
Kanie N; Kageyama N; Kuwayama A; Nakane T; Watanabe M; Kawaoi A
J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083
[TBL] [Abstract][Full Text] [Related]
14. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours.
Fuentealba IC; Mullins JE
Histol Histopathol; 1999 Jan; 14(1):51-61. PubMed ID: 9987650
[TBL] [Abstract][Full Text] [Related]
17. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
18. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
19. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical study of type IV collagen and laminin in canine mammary tumours.
Peña L; Castaña M; Sanchez MA; Rodriguez A; Flores JM
Zentralbl Veterinarmed A; 1995 Mar; 42(1):50-61. PubMed ID: 8592880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
